November 15, 2019 UMD Home FabLab AIMLab


Hydrogels

Hydrogels

 

The Fischell Department of Bioengineering research group is the first to use molecular imprinting to capture viruses. The patented technology shows promise in treating the H5N1 virus, the cause of the avian flu. It may also lead to new treatments for diabetes and more reliable vaccines. The concept shows great promise for a number of health care advances.

Called a "virus sponge," Professor Kofinas uses an inexpensive hydrogel to make an imprint of the target molecule and trap it as blood flows through the hydrogel. Kofinas sees a variety of cost-effective uses for the technology. He envisions machines similar to dialysis being used to remove viral infections from blood. Hepatitis and HIV could also be filtered from the blood.

Beyond viruses, Kofinas sees molecular imprinting being used in drugs and food additives to make life easier for diabetics by removing glucose. He also suggests using the technology in masks or protective clothing to prevent exposure to harmful biological agents.



May 8, 2007


«Previous Story  

 

 

Current Headlines

ChBE Ph.D. Student Wins Battery500 Young Investigators Award

Clark School Professor Elected 2019 APS Fellows

UMD Graduate Student Kang-Yi Lin Receives 2019 ALD/ALE Award

NSF Awards $1M Grant to UMD Researchers

Ghodssi Receives Senior Faculty Outstanding Research Award

University of Maryland Launches Quantum Technology Center

Mapping Nucleation Kinetics with Nanometer Resolution

MEI² Receives Two New Innovative Vehicle Technology Awards

UMD Hosts 4th Annual Machine Learning Bootcamp and Workshop

UMD Alumna Receives PECASE Award, Highest Honor Given by U.S. Government to Early Career Scientists

 

Colleges A. James Clark School of Engineering
The College of Computer, Mathematical, and Natural Sciences

Communicate Contact Us
Contact the Webmaster
Google+
Follow us on TwitterTwitter logo

Links Privacy Policy
Sitemap
RSS

Copyright The University of Maryland University of Maryland
2004-2019